Cite
A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).
MLA
Li, Junpei, et al. “A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (SST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).” Disease Markers, Aug. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1155/2021/6258865.
APA
Li, J., Cao, T., Wei, Y., Zhang, N., Zhou, Z., Wang, Z., Li, J., Zhang, Y., Wang, S., Wang, P., Cheng, N., Ye, L., Li, M., Yu, Y., Ding, C., Tan, Z., Zhan, B., He, Q., Bao, H., & Wu, Y. (2021). A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT). Disease Markers, 1–10. https://doi.org/10.1155/2021/6258865
Chicago
Li, Junpei, Tianyu Cao, Yaping Wei, Nan Zhang, Ziyi Zhou, Zhuo Wang, Jingyi Li, et al. 2021. “A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (SST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).” Disease Markers, August, 1–10. doi:10.1155/2021/6258865.